Statistics
Total Visits
Views | |
---|---|
HAPTOGLOBIN PHENOTYPE, HDL-CHOLESTEROL RAISING THERAPY (FIBRATE), AND RISK OF CARDIOVASCULAR DISEASE EVENTS WITHIN THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES (ACCORD) LIPID TRIAL | 132 |
Total Visits Per Month
March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | |
---|---|---|---|---|---|---|---|
HAPTOGLOBIN PHENOTYPE, HDL-CHOLESTEROL RAISING THERAPY (FIBRATE), AND RISK OF CARDIOVASCULAR DISEASE EVENTS WITHIN THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES (ACCORD) LIPID TRIAL | 4 | 5 | 13 | 4 | 8 | 19 | 4 |
File Visits
Views | |
---|---|
Warren-Rachel-MSc-CH&E-August-2020.pdf | 455 |
Top country views
Views | |
---|---|
United States | 75 |
China | 9 |
Canada | 7 |
Japan | 6 |
Russia | 5 |
Vietnam | 5 |
Ireland | 4 |
Argentina | 3 |
Australia | 2 |
Bulgaria | 2 |
Top cities views
Views | |
---|---|
Blue Bell | 11 |
Houston | 9 |
Oakland | 8 |
Tokyo | 6 |
Wilmington | 6 |
Fairfield | 5 |
Hanoi | 5 |
Dublin | 4 |
Menlo Park | 4 |
Ottawa | 4 |